Screening compound: LGCWDIWVCFEGNE-QFIPXVFZSA-N

Screening compound: LGCWDIWVCFEGNE-QFIPXVFZSA-N
Screening compound: LGCWDIWVCFEGNE-QFIPXVFZSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
LGCWDIWVCFEGNE-QFIPXVFZSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L728-0284

Molecular Formula

C25H27N3O3S (C25 H27 N3 O3 S)

Compound Name

1-[(3-METHYLPHENOXY)ACETYL]-N-[2-(2-PHENYL-1,3-THIAZOL-4-YL)ETHYL]PROLINAMIDE

IUPAC name

n/a

SMILES

Cc1cccc(OCC(N(CCC2)C2C(NCCc2csc(-c3ccccc3)n2)=O)=O)c1

InChI

InChI=1S/C25H27N3O3S/c1-18-7-5-10-21(15-18)31-16-23(29)28-14-6-11-22(28)24(30)26-13-12-20-17-32-25(27-20)19-8-3-2-4-9-19/h2-5,7-10,15,17,22H,6,11-14,16H2,1H3,(H,26,30)/t22-/m0/s1

InChI Key

LGCWDIWVCFEGNE-QFIPXVFZSA-N

MDL Number (MFCD)

LGCWDIWVCFEGNE-QFIPXVFZSA-N in Drug Discovery

Included in Screening Libraries

3D Mimetics PPI Library (1617 compounds)

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epigenetics Focused Set (26518 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Structure:
  • Mimetics
  • 3D
  • Mimetics
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Kinases
  • Proteases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with LGCWDIWVCFEGNE-QFIPXVFZSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound LGCWDIWVCFEGNE-QFIPXVFZSA-N?
Check Price and Availability of LGCWDIWVCFEGNE-QFIPXVFZSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of LGCWDIWVCFEGNE-QFIPXVFZSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for LGCWDIWVCFEGNE-QFIPXVFZSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for LGCWDIWVCFEGNE-QFIPXVFZSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of LGCWDIWVCFEGNE-QFIPXVFZSA-N available by request